Genomics Market Analysis and Reports | Italy Conference Series

Market Analysis - Genomics 2020

Genomics 2020 brings together resources and expertise to bridge Genomics & Molecular Biology to disclose significant global discoveries in Human Health. It provides a great platform to cover recent breakthroughs in Genomics, Molecular Biology, Bioinformatics, Plant Genomics, new genomic tools and its allied areas. The theme of the conference will focus the on translating genomic advances into Human Benefits and to address current trends in Genomics for better future.

The global genomics market size is expected to reach USD 27.61 billion by 2025. It is anticipated to expand at a CAGR of 8.6% during the forecast period. The previous decades have seen critical changes in ailment the executives forms because of concurrent headways in genomics and customized prescription. There has been a continuous development in the use of genomic thinks about in clinical practices, which is reflected by the developing pattern of focused treatments. Results from genomic thinks about empower a superior comprehension of maladies and the basic instruments for analysts, doctors, and consumers.This encourages proof based basic leadership, and thus, improves customized treatment system.

Moreover, mechanical headways in information examination instruments have inspired human services network to make exactness based treatments from overflow, accessible DNA information. Capacity of the therapeutic network to utilize the accessible genomic data in customized drug is foreseen to fundamentally affect the genomics advertise. Besides, diving cost of sequencing has empowered the entire genome sequencing at less cost. Researchers are consolidating the sequencing created information with diagnostics which has demonstrated its adequacy in upgrading customized treatment scene.

The organizations are engaged with key unions with worldwide just as neighborhood substances to support their income age and improve their piece of the pie. For example, in March 2017, Foundation Medicine teamed up with Bristol-Myers Squibb Company, because of which Bristol-Myers Squibb could send Foundation Medicine's atomic data arrangements and exhaustive genomic profiling for recognizable proof of prescient biomarkers, for example, Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to quicken its immunotherapy clinical preliminaries. NGS-based administrations held a significant piece of the overall industry in the administrations fragment because of its fast appropriation of entire genome sequencing and use of grouping databases for sickness screening and prognosis.The request would stay solid with the extension of the client base from constrained to scholastic and research focuses to CROs, biotech and pharma players.

As patients are concentrating on their wellbeing, Direct-To-Consumer (DTC) research facility testing is progressively being utilized. DTC hereditary tests empower customers to get to data about their hereditary qualities without fundamentally remembering medicinal services experts for the procedure.

Further key discoveries from the report recommend:

• High request as far as volume combined with the significant expense of explicit reagents add to generous income share. Organizations are grasping the pattern of offering changed reagents that improve work process

• Use of prescient biomarkers for conclusion and checking make disease annihilation a stride further. In addition, associations and projects, for example, the National Biomarker Development Alliance (NBDA) are effectively taking part being developed of novel biomarkers for malignant growth conclusion

• Growing enthusiasm of pharmaceutical and biotechnology organizations in genomics is relied upon to drive development of the genomics advertise in the inevitable years

• Asia Pacific is foreseen to show the greatest potential and a become a developing business sector for genomics. It is foreseen to enroll the quickest CAGR of 10.4% over the conjecture time frame

• Major players incorporate BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc; Foundation Medicine, Inc, 23andMe, Inc, Danaher, Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc

The global genomics market size was estimated at USD 15.48 billion in 2018 and is anticipated to expand at a CAGR of 8.6% over the forecast period. The development of genomic information pool due research exercises has empowered doctors, researcher, and patients to additionally explore the hereditary inclination to specific illnesses. Clinical utilization of this information pool is required to assume a significant job in changing the medicinal services framework as for the arrangement of increasingly precise, viable, and dependable sickness the executives arrangements.


Albeit clinical utilization of genomic information is at a beginning stage in present, the social insurance and research network are making endeavors for compelling joining of hereditary data into clinical work processes. A few clinical focuses, for example, Stanford Health Care and other malignant growth inquire about focuses, have started utilizing the accessible genomic data to devise customized treatment system. This, thusly, helps in crossing over any barrier between translational research and clinical analysis and treatment.

Worthwhile development is foreseen in regards to the usage of human hereditary thinks about into different general wellbeing projects such buyer health programs, populace screening, and others. The projects are basically planned for improving preventive consideration for regular ceaseless sicknesses, for example, malignancy and coronary illness.

Developing venture by government bodies, subsidizing offices, and biotechnology organizations to quicken genomic explore is foreseen to have significant implications on reshaping the genomics showcase. Worldwide subsidizing bodies like NIH and Welcome Trust are occupied with giving assets to hereditary examines, which thus, is relied upon to fuel genomic ponders in both created just as developing nations.

One of the most significant elements foreseen to affect this market is how a lot and to what degree the restorative network will utilize accessible genomic data in customized medication. Researchers are joining the information created from sequencing with diagnostics, which has demonstrated successful in upgrading customized treatment scene.

Importance & Scope:

Genomics is a discussion for depicting the improvement of genome-scale advancements and their application to all zones of natural examination. ... Points inside the extent of Genomics incorporate, yet are not restricted to: • Genomics including genome ventures, genome sequencing, and genomic advancements and novel systems.

Potential advantages of genomics

  • Clinical diagnostics and prescient testing
  • Distinguishing new treatment
  • Creating preventive measures
  • Direct financial advantages

The human genome is the reason for building up an assortment of items to improve the ID, treatment and counteractive action of sick wellbeing.

1. ID of ailment qualities can have applications in clinical diagnostics and prescient testing. For instance, the polymerase chain response (PCR) strategy, a profoundly touchy and precise genome-based analytic technique that duplicates the DNA of a pathogen making it simpler to recognize, can be rearranged for use in poor nations to analyze irresistible ailments, for example, leishmaniasis and dengue fever, all the more quickly, precisely and at less cost.

2. New treatment can be created by recognizing new tranquilize targets or fitting medications to explicit hereditary attributes of people. Eg differential medication retention can impact dosing levels and reactions.

3. In created preventive measures, genomics can, for instance, help distinguish various immunization targets, valuable in creating antibodies for living beings with a complex multi-have life cycle, for example, the jungle fever parasite.

Genomics will likewise be a noteworthy supporter of the biotechnology segment, which has significant pay producing potential, expected to develop from US$2.2 billion out of 1999 to US$8.2 billion of every 2004. This won't just profit created nations. Eg Cuba, putting intensely since the 1980's in biotechnology, creates a few fruitful items, including the world's just meningitis B immunization and holding at any rate 400 licenses in the biotech field.

Notwithstanding, to receive direct monetary reward from genomics, nations should be dynamic members in the improvement and assembling of genomics items. Those nations that will profit the most from genomics are those that have proper wellbeing items to improve the soundness of their populaces and who are dynamic in creating and providing those items.

Genomics is helping specialists find why a few people become ill from specific diseases, ecological factors, and behaviour's, while others don't. For instance, there are a few people who practice their entire lives, eat a sound eating routine, have customary medicinal registration, and pass on of a respiratory failure at age 40. There are additionally individuals who smoke, never work out, eat unfortunate nourishments and live to be 100. Genomics may hold the way to understanding these distinctions.

Aside from mishaps, genomic factors assume a job in nine of the ten driving reasons for death in the United States (for instance, coronary illness, malignant growth and diabetes. See: Leading Causes of Death. Every single individual are 99.9 percent indistinguishable in their hereditary cosmetics. Contrasts in the staying 0.1 percent hold significant intimations about the reasons for ailments. Increasing a superior comprehension of the communications among qualities and the earth by methods for genomics is helping specialists discover better approaches to improve wellbeing and avert infection, for example, altering consume less calories and exercise intends to avoid or postpone the beginning of type 2 diabetes in individuals who convey hereditary inclinations to building up this illness.

Target Audience:

Presidents or Vice Presidents/ Directors of Associations and Societies, CEO’s of the companies associated with regenerative medicine and tissue engineering Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (digital and mobile technology, P-O-P design, retail design, and retail execution), Professors and Students from Academia in the study of Marketing and Advertising filed.

Target Audience:

  • Industry        40%
  • Academia     50%
  • Others          10%

Associations and Societies

  1. Genetics Society of America (GSA)
  2. American College of Medical Genetics (ACMG)
  3. American Board of Medical Genetics (ABMG)
  4. American Board of Genetic Counselors (ABGC)
  5. Association of Professors of Human and Medical Genetics (APHMG)
  6. International Federation of Human Genetics Societies (IFHGS)
  7. International Genetic Epidemiology Society (IGES)
  8. International Genetics Education Network (IGEN)
  9. The Jackson Laboratory
  10. National Society of Genetic Counselors
  11. The Human Genome Organization
  12. American Society of Human Genetics
  13. European Society of Human Genetics
  14. Japan Society of Human Genetics
  15. Genetic Society in China
  16. Hong Kong Society of Medical Genetics
  17. Argentine Society of Medical Genetics
  18. Ibero-American Society of Human Genetics of North America
  19. Latin American Network of Human Genetics Societies



1.       Merck

2.       Gilead Sciences

3.       Sanofi

4.       Novartis

5.       Pfizer

6.       Roche

7.       Abbott Laboratories

8.       Novo Nordisk

9.       Valeant Pharmaceuticals

10.     Johnson & Johnson

11.     Eli Lilly & Co

16.     Universe Kogaku America Inc

17.     Object research system Inc

18.     XENPAK Transceiver R&D

19.     Caliper Life Sciences

20.     Molecular Imaging Services, Inc.

21.     CellSight Technology

22.     Affibody AB

23.     Academy of Molecular Imaging (AMI)

24.     ICON Medical Imaging

25.     Photon Lines Ltd